Literature DB >> 30166697

IS "OVARIAN" CANCER A MISNOMER? EXPLORING OVARIAN CANCER ORIGINS IN THE MOUSE.

Kathleen R Cho1.   

Abstract

Ovarian cancer is a generic term that encompasses several different tumor types. The most common and lethal type is known as high-grade serous carcinoma. The cellular origin of high-grade serous carcinoma has been debated for many years, but recent studies suggest that many, if not most, arise from epithelium in the fallopian tube rather than from the ovarian surface epithelium. Genetically engineered mice have been used to study the consequences of transforming epithelium in the oviduct (mouse fallopian tube equivalent) versus the ovarian surface epithelium, and to test whether genetic alterations characteristic of specific types of human ovarian cancers will lead to morphologically and biologically similar tumors in the mouse. Recent studies show that the mouse tumor phenotype is highly dependent on both cell of origin and the specific genetic alterations underlying neoplastic transformation, with mouse tumors based on transformation of oviductal epithelium more closely recapitulating their human tumor counterparts than those based on ovarian surface epithelium transformation. Understanding the cellular origins of ovarian cancer has significant implications for improving ovarian cancer prevention and early detection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30166697      PMCID: PMC6116583     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  33 in total

1.  Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.

Authors:  Melinda S Yates; Larissa A Meyer; Michael T Deavers; Molly S Daniels; Elizabeth R Keeler; Samuel C Mok; David M Gershenson; Karen H Lu
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-28

2.  High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.

Authors:  Yali Zhai; Rong Wu; Rork Kuick; Michael S Sessine; Stephanie Schulman; Megan Green; Eric R Fearon; Kathleen R Cho
Journal:  J Pathol       Date:  2017-07-25       Impact factor: 7.996

3.  Ovarian Cancer Is an Imported Disease: Fact or Fiction?

Authors:  Elisabetta Kuhn; Robert J Kurman; Ie-Ming Shih
Journal:  Curr Obstet Gynecol Rep       Date:  2012-03

Review 4.  Why have ovarian cancer mortality rates declined? Part I. Incidence.

Authors:  Victoria Sopik; Javaid Iqbal; Barry Rosen; Steven A Narod
Journal:  Gynecol Oncol       Date:  2015-06-14       Impact factor: 5.482

5.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

6.  3 to 5 Years Later: Long-term Effects of Prophylactic Bilateral Salpingectomy on Ovarian Function.

Authors:  Roberta Venturella; Daniela Lico; Massimo Borelli; Maria G Imbrogno; Gabriele Cevenini; Errico Zupi; Fulvio Zullo; Michele Morelli
Journal:  J Minim Invasive Gynecol       Date:  2016-09-13       Impact factor: 4.137

7.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

Review 8.  Cancer Prevention: Obstacles, Challenges and the Road Ahead.

Authors:  Frank L Meyskens; Hasan Mukhtar; Cheryl L Rock; Jack Cuzick; Thomas W Kensler; Chung S Yang; Scott D Ramsey; Scott M Lippman; David S Alberts
Journal:  J Natl Cancer Inst       Date:  2015-11-07       Impact factor: 13.506

9.  Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.

Authors:  Isaac Kinde; Chetan Bettegowda; Yuxuan Wang; Jian Wu; Nishant Agrawal; Ie-Ming Shih; Robert Kurman; Fanny Dao; Douglas A Levine; Robert Giuntoli; Richard Roden; James R Eshleman; Jesus Paula Carvalho; Suely Kazue Nagahashi Marie; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

10.  Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Authors:  Rong Wu; Neali Hendrix-Lucas; Rork Kuick; Yali Zhai; Donald R Schwartz; Aytekin Akyol; Samir Hanash; David E Misek; Hidetaka Katabuchi; Bart O Williams; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.